Public archive
AimedBio partners with Boehringer Ingelheim (26 Oct 2026)
Updated November 6, 2026
AimedBio partners with Boehringer Ingelheim on 26 October 2026. The agreement covers global.
Event data
- Company
- AimedBio
- Partner Company
- Boehringer Ingelheim
- Partnership Type
- commercial
- Deal Scope
- global
- Products Involved
- BI 4060107
- Strategic Purpose
- advance ADC into clinical development for solid tumors
- Sector
- Biotechnology
- Country
- South Korea
- Announcement Date
- 2026-10-26
Subscribers saw this 9 days earlier.
Source
businesswire.com